Persica completes recruitment into Trial assessing efficacy of PP353
Peter Hamlyn, Founder and Director of Persica Pharmaceuticals will be presenting at the British Association of Spine Surgeons London, UK, 24 March 2022 – Persica Pharmaceuticals Ltd, a clinical stage...